September 12-13
Caesars Palace
Las Vegas, NV
Register
Here!
Head to AAJ's Pharmaceutical Seminar in Las
Vegas to get the latest information on how you—plaintiff
trial lawyers—are holding the pharmaceutical industry
accountable. At this acclaimed seminar, you'll gain insight
from experienced trial attorneys who've handled cases against
pharmaceutical companies nationwide, including that latest
updates on today's hot topics in pharmaceutical litigation.Register
Now!
|
In the Spring 2008 Newsletter
The Next Mass Tort: Chantix®
By Kristian Rasmussen and Elizabeth Chambers,
Birmingham, AL
Chantix®, known generically as varenicline, is a smoking
cessation drug. The FDA has recently linked Chantix® to
cases of suicide, suicidal thoughts, violent behavior, and other
psychological adverse events.
Late last year, in November 2007, the Food and Drug Administration
(FDA) announced the results of its preliminary assessment of
Chantix®. The FDA specifically highlighted the number of
reports noting the association between suicide and attempted
suicide “within days to weeks of initiating Chantix treatment.”1
Many of the cases were reported for patients without any prior
history of psychiatric illness. Currently, government scientists
are conducting further investigations into the drug and . .
.
Read More
| Join
This Section!
Join the Chantix Litigation Group |
Your Free CLE Reference Materials
HOW TO SURVIVE REVERSE
BIFURCATION AND OTHER INSIDIOUS DEFENDANT LAND MINES: HORMONE
THERAPY LITIGATION EXAMPLE
By Robert K. Jenner
1. To Reverse or Not to Reverse, That Is the Question
a. Reverse bifurcation defined: Defendants seek to have some
pharmaceutical cases bifurcated. That means that the case is
split into two parts: liability and damages.
(1) Phase I: The damages portion addresses whether the defendant’s
drug caused the plaintiff’s damages, and asks the jury
to determine the amount of those damages
(2) Phase II: The liability portion addresses whether the defendant
violated the standard of care.
Read More
| Join
This Section!
This paper, available free to members of the Section
on Toxic, Environmental, and Pharmaceutical Torts (STEP), was
presented at the 2007 AAJ Annual Convention in Chicago. Copyright
© 2007 American Association for Justice. Further reproduction
of any kind is prohibited. For more information, call AAJ Education
at (800) 622-1791. To purchase other papers, visit the AAJ
Exchange. |
CLE Programs
Listen to your Section's Education Program from the Chicago
Annual Convention. STEP members save 25% off recordings
from the Section on Toxic, Environmental, and Pharmaceutical
Torts (STEP)'s Convention education programs. Call AAJ's multimedia
provider, iPlayback, at 800-241-7785 or 770-447-0616 or visit
the Web site at www.iplaybackAAJ.com.
Other Education Programs
| Teleseminar Schedule |
|
 |
|
|
|
Certain Section benefits in membership types other
than Regular, Sustaining, Life, or President’s Club may
be restricted. For more information, please visit the Sections
Home page or call AAJ Sections at 800-424-2725, ext. 700. |
| About
the Section on Toxic, Environmental, and Pharmaceutical Torts
(STEP)
Section Leadership
Section Bylaws |
Contact
AAJ Sections
777 6th Street, NW
Washington, DC 20001
(800) 424-2725
(202) 965-3500, ext 700
sections@justice.org |
Exchange Case Preparation
VoirDireBase.com
has over 2,500 voir dire questions in almost 200 categories-all
trial tested. As an AAJ member, receive $75 off the regular
subscription price. |
|
The Section on Toxic, Environmental, and
Pharmaceutical Torts (STEP) is Endowed by David S. Shrager
|
|
